CVS admits no wrongdoing in the case that claims the violations stemmed from corporate-imposed performance metrics, compensation and staffing policies.
CVS has agreed to pay $315 million to resolve allegations that it illegally filled prescriptions for opioids and other controlled substances and then sought payment from Medicare and other federal programs, according to the Department of Justice.
The claims resolved by the settlement are allegations only, and there has been no determination of liability, the DOJ said.
The DOJ said the settlement resolves a civil lawsuit filed by Hillary Estright, a former CVS employee and a whistleblower authorized under the False Claims Act to sue on behalf of the United States and receive a share of the recovery. No amount has been determined.
CVS denies wrongdoing, telling Healthcare Finance News, "Our more than 27,000 CVS pharmacists do their part to help keep America healthy and are highly trained in the safe and appropriate use of all medications. We've implemented best-in-class and first-of-their-kind programs to help our pharmacists make the best decisions on behalf of patients. We strongly disagree with the claims made in this case, and our settlement with the DOJ admits no wrongdoing. We're pleased to move forward and put this litigation behind us."
The United States, which intervened in the case, filed the complaint on Dec. 13, 2024, in federal court in Rhode Island. It alleges that CVS violated the Controlled Substances Act and...
Minister has not withdrawn, rescinded or amended any of the geographical name changes Minister Gayton McKenzie rejects false claims on Graaff-Reinet renaming 12 October 2026 The Ministry of Sport, ...